Be Ready to Expedite Treatment for Malignant Hyperthermia

Hospitals are striving to meet expectations for treating malignant hyperthermia.

About one in 2,000 people are at risk for malignant hyperthermia from exposure to anesthetic gases (desflurane, etc) or succinylcholine.

These patients can have muscle rigidity, hyperthermia, tachycardia, or hypercapnia from uncontrolled calcium release in the muscle...which can lead to rhabdomyolysis, arrhythmias, acute kidney injury, and death.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals